Electrochemical Detection of SARS-CoV-2 Using Immunomagnetic Separation and Gold Nanoparticles on Unmodified Screen-Printed Carbon Electrodes

Abstract

The COVID-19 pandemic has underscored the critical need for virus detection methods that are precise, simple, quick, and cost-effective. Electrochemical immunoassay-based methods are a practical solution given their ability to quickly, inexpensively, sensitively, and selectively detect the virus at the point of care. This study details the immunomagnetic capture of SARS-CoV-2 nucleocapsid protein in nasal samples, followed by electrochemical detection using gold nanoparticle labels on a screen-printed carbon electrode. We determined ideal conditions for the size of the gold nanoparticles and the length of the deposition time to maximize the electrochemical signal. The limit of detection for nucleocapsid protein was determined to be 2.64 ng/mL in PBS. The assay was successfully demonstrated to detect nucleocapsid protein in SARS-CoV-2-positive samples with a viral load as low as Ct = 25 (p-value < 0.0001 vs. negative patient control).